Panacea Biotec and Sanofi Healthcare India have reached a settlement agreement over a patent infringement lawsuit concerning a fully liquid hexavalent vaccine. Sanofi has agreed not to launch its ...
Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to ...
Panacea Biotec shares touched a new 52-week high on Tuesday after Sanofi Healthcare India agreed to not commercially produce its fully liquid hexavalent vaccine Shan6 in India, directly or ...